{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-011367","form_type":"8-K","ticker":"HRGN","cik":"0001563665","company_name":"Harvard Apparatus Regenerative Technology, Inc.","filed_at":"2022-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.001444+00:00","generated_at":"2026-06-27T11:41:34.688159+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"Biostage posts webinar video; interim CEO outlines plans for clinical trial, capital raise, NASDAQ uplisting","bullets":["Biostage posted video of January 27 webinars with founder/interim CEO David Green.","Webinar covered plans for approved clinical trial, raising capital, and uplisting to NASDAQ.","Video includes Q&A sessions from both webinars."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-011367","json":"https://secwatch.observer/filing/0001104659-22-011367.json","markdown":"https://secwatch.observer/filing/0001104659-22-011367.md","text":"https://secwatch.observer/filing/0001104659-22-011367.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563665/000110465922011367/0001104659-22-011367-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563665/000110465922011367/tm225487d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T11:41:34.688159+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}